Irrespective of progress in investigation, evidence regarding the wellness consequences of cannabis use stays elusive and there's no consensus in the clinical Group about which ailments it may possibly handle.5In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis as being a Program III drug. This resched